ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

New ACS Program Honors Mary Lasker

August 31, 1984

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013